U.S. FDA Grants Approval for Ranitidine Comeback Medical Dialogues Team20 Jan 2026 10:48 AM ISTDecember 6, 2025: The U.S. Food and Drug Administration (US FDA) in November 2025 has approved reformulated ranitidine tablets, marking the return of...
FOGSI Expert Consensus Review Redefines Landscape of Endometriosis Management with Elagolix: 5 Key Takeaways Swapnil Sharma12 Jan 2026 11:30 AM ISTEndometriosis is a chronic, estrogen-dependent condition affecting an estimated 10% of women of reproductive age worldwide and is a leading cause of...
FOGSI Consensus Redefines Endometriosis Care with Oral GnRH Antagonist, Elagolix Anshika Mishra2 Jan 2026 11:43 AM ISTIn a new key clinical update in endometriosis management, the Federation of Obstetric and Gynaecological Societies of India (FOGSI) has released an...
Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman Deeksha Bhandari13 Nov 2025 6:00 PM ISTOn this World Diabetes Day, we bring you a special episode of Dia Dialogues titled "Gliclazide - Revisiting a Preferred Sulphonylurea in 2025." ...
Reimagining Medical Learning and Research: The Role of Intelligent Platforms Deeksha Bhandari12 Nov 2025 12:07 PM ISTIn this episode of Medical Dialogues Show, Ruchi Tushir, VP and GM at Wolters Kluwer, Global Growth Market, India, shares valuable insights on how...
Why Wellness Planning and Health Insurance are Both Crucial for Financial Security? MD Brand Connect7 Oct 2025 12:43 PM ISTFinancial planning isn't complete without taking your health into account. Wellness planning and health insurance work together to reduce medical...
Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer Deeksha Bhandari22 Sept 2025 5:47 PM ISTAlkem aims to expand access to treatment with its affordable pertuzumab biosimilar that meets global standards and is backed by trusted science ...
Managing Nasal Congestion in Allergic Rhinitis: Whats the Mechanism of Action of Allegra D ? Deeksha Bhandari1 Sept 2025 12:45 PM ISTAllegra-D is a Schedule H prescription drug. To be sold by retail on the prescription of a Registered Medical Practitioner only.Allergic rhinitis...
PCV20 Launch in India: A Single Dose, Science-Driven Approach for Pneumococcal Disease Control Deeksha Bhandari14 Aug 2025 12:12 PM ISTA next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new milestone in adult ...
Tirzepatide superior to Semaglutide- SURMOUNT-5 Trial Results Deeksha Bhandari11 Aug 2025 12:54 PM IST In SURMOUNT-5 Treatment with tirzepatide MTD (10 or 15 mg) was superior to semaglutide MTD (1.7 or 2.4 mg) with respect to reduction in...
Sanofi Consumer Healthcare India Limited launches Allegra-D in India: Non-Drowsy Allergy Relief with Nasal Decongestion Deeksha Bhandari8 Aug 2025 11:29 AM ISTSanofi Consumer Healthcare India Limited, one of India's leading consumer healthcare organisations, has announced the launch of Allegra-D, a...
First Hybrid Endoscopic-Microscopic ENT Skill Lab Inaugurated at Dr. D.Y. Patil Medical College, Hospital & Research Centre MD Brand Connect30 July 2025 5:47 PM ISTPune: A revolutionary leap in surgical education unfolded in Pune as Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune,...
